Abstract
Inflammatory bowel disease (IBD) is rarity after renal transplantation. Immunosuppressive therapy forms the cornerstone for the treatment of IBD. Ideally, IBD should not occur in this immunosuppressive state. However, local activation and dysregulation in the mucosal immune system has been proposed after tacrolimus and mycophenolate after renal transplantation. Our case report describes a very early-onset IBD after renal transplant which is hardly reported in literature.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
